RNXT
RenovoRxยทNASDAQ
--
--(--)
--
--(--)
RNXT Profile
Renovorx, Inc.
A clinical-stage biopharmaceutical company that developing local therapies for solid tumors
2570 West El Camino Real, Suite 320, Mountain View, CA 94040
--
RenovoRx, Inc., was incorporated in Delaware on December 17, 2012. The Company is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for highly unmet medical needs with the goal of improving treatment outcomes for cancer patients undergoing treatment. The Company's proprietary Transarterial Microperfusion (TAMPT) treatment platform is designed to ensure precise treatment delivery to directly target the tumor while potentially minimizing the toxicity of the treatment relative to systemic (intravenous (referred to as "IV ") treatment).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
